Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
Diabetes, insulin resistance and sugars
Nausea (44%), diarrhoea (30%), vomiting (24%), and constipation (24%)
Semaglutide works by binding to GLP-1 receptors in the brain, particularly in areas that control appetite and food intake, leading to reduced hunger and increased feelings of fullness
GLP-1 receptor agonists reduce inflammatory cytokines, improve insulin resistance, aid gut health, and help lower the chronic inflammation that drives many forms of arthritis, as well as metabolic and heart diseases. Are GLP-1 medications safe, and who should not use them
Many patients report noticeable improvements in energy levels, sleep quality, and body composition within 1-3 months of consistent use